204 related articles for article (PubMed ID: 20558351)
1. [Hepatitis B virus (HBV) infection and hepatocarcinogenesis].
Pár A
Orv Hetil; 2010 Jun; 151(26):1045-53. PubMed ID: 20558351
[TBL] [Abstract][Full Text] [Related]
2. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
Lim SG; Mohammed R; Yuen MF; Kao JH
J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():144-52. PubMed ID: 21199526
[TBL] [Abstract][Full Text] [Related]
5. Prevention of hepatocellular carcinoma and its recurrence with anti-hepatitis B viral therapy.
Halegoua-De Marzio D; Hann HW
Minerva Gastroenterol Dietol; 2014 Sep; 60(3):191-200. PubMed ID: 25000955
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus in hepatocarcinogenesis.
Feitelson MA
J Cell Physiol; 1999 Nov; 181(2):188-202. PubMed ID: 10497299
[TBL] [Abstract][Full Text] [Related]
7. Genetic basis of hepatitis virus-associated hepatocellular carcinoma: linkage between infection, inflammation, and tumorigenesis.
Takeda H; Takai A; Inuzuka T; Marusawa H
J Gastroenterol; 2017 Jan; 52(1):26-38. PubMed ID: 27714455
[TBL] [Abstract][Full Text] [Related]
8. Preventing infection-associated cancer: from bench to hillside.
Goedert JJ
J Natl Cancer Inst; 2005 Feb; 97(4):245-6. PubMed ID: 15713953
[No Abstract] [Full Text] [Related]
9. [Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma].
Pár A
Orv Hetil; 2009 Jan; 150(1):19-26. PubMed ID: 19091671
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of HBV-associated hepatocarcinogenesis.
Guerrieri F; Belloni L; Pediconi N; Levrero M
Semin Liver Dis; 2013 May; 33(2):147-56. PubMed ID: 23749671
[TBL] [Abstract][Full Text] [Related]
11. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.
Ringelhan M; O'Connor T; Protzer U; Heikenwalder M
J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus-induced hepatocellular carcinoma.
Xu C; Zhou W; Wang Y; Qiao L
Cancer Lett; 2014 Apr; 345(2):216-22. PubMed ID: 23981576
[TBL] [Abstract][Full Text] [Related]
13. Integrated hepatitis B virus X and 3' truncated preS/S sequences derived from human hepatomas encode functionally active transactivators.
Schlüter V; Meyer M; Hofschneider PH; Koshy R; Caselmann WH
Oncogene; 1994 Nov; 9(11):3335-44. PubMed ID: 7936659
[TBL] [Abstract][Full Text] [Related]
14. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
Liaw YF
Semin Liver Dis; 2005; 25 Suppl 1():40-7. PubMed ID: 16103980
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma and hepatitis B surface protein.
Li YW; Yang FC; Lu HQ; Zhang JS
World J Gastroenterol; 2016 Feb; 22(6):1943-52. PubMed ID: 26877602
[TBL] [Abstract][Full Text] [Related]
16. Virus-induced hepatocellular carcinoma with special emphasis on HBV.
Wang M; Xi D; Ning Q
Hepatol Int; 2017 Mar; 11(2):171-180. PubMed ID: 28097530
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of HBV-related hepatocarcinogenesis.
Neuveut C; Wei Y; Buendia MA
J Hepatol; 2010 Apr; 52(4):594-604. PubMed ID: 20185200
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B vaccines: protective efficacy and therapeutic potential.
Michel ML; Tiollais P
Pathol Biol (Paris); 2010 Aug; 58(4):288-95. PubMed ID: 20382485
[TBL] [Abstract][Full Text] [Related]
19. Hepatocarcinogenesis in viral Hepatitis B infection: the role of HBx and p53.
Dewantoro O; Gani RA; Akbar N
Acta Med Indones; 2006; 38(3):154-9. PubMed ID: 16953033
[TBL] [Abstract][Full Text] [Related]
20. Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible?
Calvaruso V; Craxì A
Liver Int; 2014 Feb; 34 Suppl 1():85-90. PubMed ID: 24373083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]